Mirum Pharmaceuticals (MIRM)
(Real Time Quote from BATS)
$52.94 USD
+1.10 (2.12%)
Updated Aug 6, 2025 12:10 PM ET
3-Hold of 5 3
D Value A Growth B Momentum B VGM
Fundamental Charts
About Market Cap
As of the previous market close, Mirum Pharmaceuticals, Inc. has a market cap of $2.57B, which represents its share price of $51.84 multiplied by its outstanding shares number of 49.53M. As a mid-cap company, MIRM's shareholders are generally exposed to less risk than shareholders of small-cap companies but more risk than large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
MIRM 52.94 +1.10(2.12%)
Will MIRM be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for MIRM based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for MIRM
Agios Pharmaceuticals (AGIO) Reports Q2 Loss, Beats Revenue Estimates
Mirum Pharmaceuticals, Inc. (MIRM) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
MIRM: What are Zacks experts saying now?
Zacks Private Portfolio Services
Mirum Gains 35% in 3 Months: How Should You Play the Stock?
EMA Accepts GSK's Filing for Linerixibat in Rare Disease-Related Itch
Why Is Editas (EDIT) Up 40% Since Last Earnings Report?
Other News for MIRM
Here are the major earnings after the close Wednesday
Earnings Scheduled For August 6, 2025
ClearBridge Small Cap Growth Portfolios Q2 2025 Commentary
ClearBridge Small Cap Growth Fund Q2 2025 Commentary
Mirum Pharmaceuticals Inc (MIRM) Announces Upcoming Second Quarter 2025 Financial Results | ...